Solara Active Pharma Sciences - Pure Play API

[Rishu1202]

Pharma || Hospitals || Diagnostics : Industry perspective

We have a very good news of Mosquirix approved by WHO. " Despite its approval for use, it is only 30% effective at preventing severe cases, requires four doses and the protection it gives fades after a few months. Although side effects are rare, they could include fever and convulsions."

One of the key products of Solara, the API for Antimalarial drug - Artemether will be impacted due to this.